v3.25.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Revenues      
Total revenues $ 4,637.2 $ 4,812.6 $ 3,911.4
Operating costs and expenses      
Operating expense, excluding depreciation and amortization below 1,679.4 1,691.5 1,528.4
Rent 873.6 873.5 886.2
General and administrative:      
Merger, acquisition and other costs 0.1 1.7 2.1
Other, excluding depreciation and amortization below 226.8 241.9 207.6
Depreciation and amortization 319.5 365.0 396.0
Impairment of long-lived assets 72.3 106.9 133.1
Operating costs and expenses 4,716.5 4,886.9 4,433.7
Operating loss (79.3) (74.3) (522.3)
Other expense, net:      
Other expense (income) (156.2) (76.8) 55.2
Interest expense:      
Corporate borrowings 401.8 369.6 336.4
Finance lease obligations 5.4 3.7 4.1
Non-cash NCM exhibitor services agreement 36.5 37.9 38.2
Investment expense (income) (16.3) (15.5) 14.9
Total other expense, net 271.2 318.9 448.8
Loss before income taxes (350.5) (393.2) (971.1)
Income tax provision 2.1 3.4 2.5
Net loss $ (352.6) $ (396.6) $ (973.6)
Net loss per share:      
Basic (in dollars per share) $ (1.06) $ (2.37) $ (9.29)
Diluted (in dollars per share) $ (1.06) $ (2.37) $ (9.29)
Weighted average shares outstanding:      
Basic (Shares in thousands) 332,920 167,644 104,769
Diluted (Shares in thousands) 332,920 167,644 104,769
Admissions      
Revenues      
Total revenues $ 2,560.5 $ 2,690.5 $ 2,201.4
Operating costs and expenses      
Operating costs and expenses 1,239.2 1,291.1 1,051.7
Food and beverage      
Revenues      
Total revenues 1,624.9 1,669.8 1,313.7
Operating costs and expenses      
Operating costs and expenses 305.6 315.3 228.6
Other theatre      
Revenues      
Total revenues $ 451.8 $ 452.3 $ 396.3

Source

10-K PDF
XBRL